Cargando…
Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses
COVID-19, first reported in late 2019, is an ongoing pandemic that has been causing devastation across the globe. Although there are multiple vaccines that can prevent severe symptoms, effective COVID-19 therapeutics are still of importance. Using our proprietary in silico engine, we screened more t...
Autores principales: | Shen, Zhewei, Halberg, Anna, Fong, Jia Yi, Guo, Jingyu, Song, Gavin, Louie, Brent, Luedtke, Gregory R., Visuthikraisee, Viwat, Protter, Andrew A., Koh, Xiaoying, Baik, Taegon, Lum, Pek Yee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637228/ https://www.ncbi.nlm.nih.gov/pubmed/36335206 http://dx.doi.org/10.1038/s41598-022-21984-w |
Ejemplares similares
-
Repurposing Nucleoside Analogs for Human Coronaviruses
por: Zandi, Keivan, et al.
Publicado: (2020) -
Elucidating coronavirus fusion mechanisms
por: Hess, Tobin, et al.
Publicado: (2023) -
Perspectives for repurposing drugs for the coronavirus disease 2019
por: Cherian, Sarah S., et al.
Publicado: (2020) -
Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020) -
Strategies for drug repurposing against coronavirus targets
por: Smith, Poppy O., et al.
Publicado: (2021)